These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 31350659)
41. Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire. Ferner RE; Thomas M; Mercer G; Williams V; Leschziner GD; Afridi SK; Golding JF Health Qual Life Outcomes; 2017 Feb; 15(1):34. PubMed ID: 28193237 [TBL] [Abstract][Full Text] [Related]
42. Validation and Psychometric Properties of the German Version of the SWAL-QOL. Kraus EM; Rommel N; Stoll LH; Oettinger A; Vogel AP; Synofzik M Dysphagia; 2018 Aug; 33(4):431-440. PubMed ID: 29313143 [TBL] [Abstract][Full Text] [Related]
43. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326 [TBL] [Abstract][Full Text] [Related]
44. Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy. Benussi A; Dell'Era V; Cantoni V; Turrone R; Pilotto A; Alberici A; Cotelli MS; Rizzetti C; Padovani A; Borroni B Brain Stimul; 2019; 12(5):1290-1297. PubMed ID: 31155302 [TBL] [Abstract][Full Text] [Related]
45. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. de la Loge C; Trudeau E; Marquis P; Kahrilas P; Stanghellini V; Talley NJ; Tack J; Revicki DA; Rentz AM; Dubois D Qual Life Res; 2004 Dec; 13(10):1751-62. PubMed ID: 15651545 [TBL] [Abstract][Full Text] [Related]
46. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Nath U; Ben-Shlomo Y; Thomson RG; Morris HR; Wood NW; Lees AJ; Burn DJ Brain; 2001 Jul; 124(Pt 7):1438-49. PubMed ID: 11408338 [TBL] [Abstract][Full Text] [Related]
47. Progressive supranuclear palsy in a sample of Brazilian population: clinical features of 16 patients. Carrilho PE; Barbosa ER Arq Neuropsiquiatr; 2002 Dec; 60(4):917-22. PubMed ID: 12563380 [TBL] [Abstract][Full Text] [Related]
48. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis. Glasmacher SA; Leigh PN; Saha RA J Neurol Neurosurg Psychiatry; 2017 May; 88(5):402-411. PubMed ID: 28250027 [TBL] [Abstract][Full Text] [Related]
49. The diagnosis of progressive supranuclear palsy: current opinions and challenges. Ali F; Josephs K Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389 [TBL] [Abstract][Full Text] [Related]
50. Appraisal of a specific scale for quality of life (AlQoL-9) in Greek alcohol dependent individuals attending: A confirmatory factor analysis. Pappa AS; Ginieri-Coccossis M; Richardson C; Charalampi A; Liappas IA; Paparrigopoulos T Psychiatriki; 2016; 27(1):17-26. PubMed ID: 27110879 [TBL] [Abstract][Full Text] [Related]
51. Quality of life impact of urge incontinence in older persons: a new measure and conceptual structure. DuBeau CE; Kiely DK; Resnick NM J Am Geriatr Soc; 1999 Aug; 47(8):989-94. PubMed ID: 10443861 [TBL] [Abstract][Full Text] [Related]
52. [Progressive supranuclear palsy-Richardson syndrome with visual attention disturbance (Holmes and Horrax) and ataxie optique (Garcin): a case report]. Morishima R; Bandoh M; Sunami Y; Isozaki E Rinsho Shinkeigaku; 2019 Nov; 59(11):730-735. PubMed ID: 31656263 [TBL] [Abstract][Full Text] [Related]
53. Reliability and Validity of The Cerebral Palsy Quality of Life Questionnaire in The Turkish Population. Atasavun Uysal S; Düger T; Elbasan B; Karabulut E; Toylan İ Percept Mot Skills; 2016 Feb; 122(1):150-64. PubMed ID: 27420313 [TBL] [Abstract][Full Text] [Related]
54. Translation and validation of the italian version of the Psychosocial Impact of Dental Aesthetics Questionnaire (pidaq) among adolescents. Bucci R; Rongo R; Zito E; Valletta R; Michelotti A; D'anto V Eur J Paediatr Dent; 2017 Jun; 18(2):158-162. PubMed ID: 28598189 [TBL] [Abstract][Full Text] [Related]
55. Validation of a stoma-specific quality of life questionnaire in a sample of patients with colostomy or ileostomy. Canova C; Giorato E; Roveron G; Turrini P; Zanotti R Colorectal Dis; 2013 Nov; 15(11):e692-8. PubMed ID: 23800245 [TBL] [Abstract][Full Text] [Related]
56. Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy. Klietz M; Eichel HV; Staege S; Kutschenko A; Respondek G; Huber MK; Greten S; Höglinger GU; Wegner F Parkinsons Dis; 2021; 2021():9990679. PubMed ID: 34046156 [TBL] [Abstract][Full Text] [Related]
57. Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoL. Gentile S; Jouve E; Dussol B; Moal V; Berland Y; Sambuc R Health Qual Life Outcomes; 2008 Oct; 6():78. PubMed ID: 18851730 [TBL] [Abstract][Full Text] [Related]
59. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review. Tilley E; McLoughlin J; Koblar SA; Doeltgen SH; Stern C; White S; Peters MD JBI Database System Rev Implement Rep; 2016 Jun; 14(6):148-95. PubMed ID: 27532657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]